Bosera Hang Seng Healthcare ETF (QDII) (SHA:513060)
0.6710
-0.0190 (-2.75%)
At close: Oct 17, 2025
SHA:513060 Holdings Information
SHA:513060 is an equity ETF with a total of 71 individual holdings. The top holdings are Innovent Biologics stock at 10.19%, BeOne Medicines AG at 8.96%, WuXi Biologics at 8.31%, CSPC Pharmaceutical Group at 5.45%, and Akeso at 5.42%.
Total Holdings
25
Top 10 Percentage
57.04%
Asset Class
Equity
ETF Category
Health Care
Assets
7.04B
PE Ratio
12.80
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | HKG: 1801 | Innovent Biologics, Inc. | 10.19% |
2 | HKG: 6160 | BeOne Medicines AG | 8.96% |
3 | HKG: 2269 | WuXi Biologics (Cayman) Inc. | 8.31% |
4 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 5.45% |
5 | HKG: 9926 | Akeso, Inc. | 5.42% |
6 | HKG: 1177 | Sino Biopharmaceutical Limited | 4.76% |
7 | HKG: 6618 | JD Health International Inc. | 4.22% |
8 | HKG: 1530 | 3SBio Inc. | 3.97% |
9 | HKG: 3692 | Hansoh Pharmaceutical Group Company Limited | 3.09% |
10 | HKG: 0241 | Alibaba Health Information Technology Limited | 2.67% |
11 | HKG: 9688 | Zai Lab Limited | 2.64% |
12 | HKG: 2359 | WuXi AppTec Co., Ltd. | 2.40% |
13 | HKG: 2367 | Giant Biogene Holding Co., Ltd. | 2.36% |
14 | HKG: 1099 | Sinopharm Group Co. Ltd. | 2.16% |
15 | HKG: 1548 | Genscript Biotech Corporation | 1.82% |
16 | HKG: 6855 | Ascentage Pharma Group International | 1.63% |
17 | HKG: 6990 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | 1.51% |
18 | HKG: 0867 | China Medical System Holdings Limited | 1.41% |
19 | INCPF | InnoCare Pharma Ltd | 1.37% |
20 | HKG: 1066 | Shandong Weigao Group Medical Polymer Company Limited | 1.33% |
21 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.31% |
22 | HKG: 1952 | Everest Medicines Limited | 1.25% |
23 | HKG: 0512 | Grand Pharmaceutical Group Limited | 1.22% |
24 | 13.HK | HUTCHMED (China) Ltd | 1.17% |
25 | HKG: 2268 | WuXi XDC Cayman Inc. | 1.10% |
As of Jun 30, 2025